Why Partner with the Allogeneic Cell Therapies Summit Europe

Whilst allogeneic cell therapies offer a variety of solutions to the shortcomings hampering the commercial success of autologous therapies, their development are still in the early stages and challenges lie ahead. The leading drug developers in the field are telling us they require meaningful partnerships to aid with research development, manufacturing, cryopreservation and logistics.

We will work with you to design a bespoke partnership package where you could:

Position Yourself as an Industry Thought Leader
Now is your chance to get in front of your target key decision makers in the market and demonstrate your expertise through podium presentations, moderating panel discussions or interactive roundtables

Raise Brand Awareness
Increase your reach and exposure to new clients, customers and businesses through unique branding opportunities pre and post conference

Meet and Network with Industry Pioneers
With a room full of drug developers looking to see how they can effectively commercialize allogeneic cell therapies, fill your pipeline with new leads for 2023 through one-to-one meetings and networking opportunities

Benefit from Market Intelligence
Discover what solutions and services pharmaceuticals and biotech will be investing in to produce allogenic cell therapies on large scales in 2023 to enable you to match your solutions accordingly

Act now to stay ahead of the curve and seize this great opportunity on offer.

Email sponsor@hansonwade.com to learn how we can help you achieve your business goals faster, more effectively, and more cost-efficiently for 2023 and beyond.